| Type |
Details |
Score |
| Publication |
| First Author: |
Sharma A |
| Year: |
2010 |
| Journal: |
J Neurosci |
| Title: |
Dysregulation of mTOR signaling in fragile X syndrome. |
| Volume: |
30 |
| Issue: |
2 |
| Pages: |
694-702 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
161
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pita-Thomas W |
| Year: |
2019 |
| Journal: |
Exp Neurol |
| Title: |
HDAC5 promotes optic nerve regeneration by activating the mTOR pathway. |
| Volume: |
317 |
|
| Pages: |
271-283 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nada S |
| Year: |
2009 |
| Journal: |
EMBO J |
| Title: |
The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. |
| Volume: |
28 |
| Issue: |
5 |
| Pages: |
477-89 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Brugarolas J |
| Year: |
2004 |
| Journal: |
Genes Dev |
| Title: |
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. |
| Volume: |
18 |
| Issue: |
23 |
| Pages: |
2893-904 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Akeno N |
| Year: |
2015 |
| Journal: |
Oncogene |
| Title: |
p53 suppresses carcinoma progression by inhibiting mTOR pathway activation. |
| Volume: |
34 |
| Issue: |
5 |
| Pages: |
589-99 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jung CH |
| Year: |
2009 |
| Journal: |
Mol Biol Cell |
| Title: |
ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. |
| Volume: |
20 |
| Issue: |
7 |
| Pages: |
1992-2003 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sinclair LV |
| Year: |
2008 |
| Journal: |
Nat Immunol |
| Title: |
Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. |
| Volume: |
9 |
| Issue: |
5 |
| Pages: |
513-21 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yu M |
| Year: |
2017 |
| Journal: |
Nat Commun |
| Title: |
PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development. |
| Volume: |
8 |
| Issue: |
1 |
| Pages: |
1457 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ma N |
| Year: |
2021 |
| Journal: |
Nat Commun |
| Title: |
PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling. |
| Volume: |
12 |
| Issue: |
1 |
| Pages: |
3059 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim S |
| Year: |
2011 |
| Journal: |
Cell Metab |
| Title: |
Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. |
| Volume: |
13 |
| Issue: |
2 |
| Pages: |
215-21 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xu G |
| Year: |
2015 |
| Journal: |
Mol Cell Endocrinol |
| Title: |
Ghrelin regulates GLP-1 production through mTOR signaling in L cells. |
| Volume: |
416 |
|
| Pages: |
9-18 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Herranz N |
| Year: |
2015 |
| Journal: |
Nat Cell Biol |
| Title: |
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. |
| Volume: |
17 |
| Issue: |
9 |
| Pages: |
1205-17 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu JT |
| Year: |
2022 |
| Journal: |
Theranostics |
| Title: |
Arterial cyclic stretch regulates Lamtor1 and promotes neointimal hyperplasia via circSlc8a1/miR-20a-5p axis in vein grafts. |
| Volume: |
12 |
| Issue: |
11 |
| Pages: |
4851-4865 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang YK |
| Year: |
2017 |
| Journal: |
Nat Commun |
| Title: |
Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. |
| Volume: |
8 |
| Issue: |
1 |
| Pages: |
464 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tsai CW |
| Year: |
2024 |
| Journal: |
Neuropharmacology |
| Title: |
Abnormal increased mTOR signaling regulates seizure threshold in Dravet syndrome. |
| Volume: |
262 |
|
| Pages: |
110166 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tsai V |
| Year: |
2014 |
| Journal: |
Cereb Cortex |
| Title: |
Fetal brain mTOR signaling activation in tuberous sclerosis complex. |
| Volume: |
24 |
| Issue: |
2 |
| Pages: |
315-27 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gentilella A |
| Year: |
2015 |
| Journal: |
Biochim Biophys Acta |
| Title: |
A liaison between mTOR signaling, ribosome biogenesis and cancer. |
| Volume: |
1849 |
| Issue: |
7 |
| Pages: |
812-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Leibowitz BJ |
| Year: |
2023 |
| Journal: |
Oncogene |
| Title: |
mTOR inhibition suppresses Myc-driven polyposis by inducing immunogenic cell death. |
| Volume: |
42 |
| Issue: |
24 |
| Pages: |
2007-2016 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Arafa SR |
| Year: |
2019 |
| Journal: |
Exp Neurol |
| Title: |
Self-reinforcing effects of mTOR hyperactive neurons on dendritic growth. |
| Volume: |
311 |
|
| Pages: |
125-134 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sun ZJ |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model. |
| Volume: |
8 |
| Issue: |
10 |
| Pages: |
e74888 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Deming DA |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
mTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers. |
| Volume: |
8 |
| Issue: |
4 |
| Pages: |
e60709 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
142
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Taub N |
| Year: |
2012 |
| Journal: |
J Cell Sci |
| Title: |
The late endosomal adaptor p14 is a macrophage host-defense factor against Salmonella infection. |
| Volume: |
125 |
| Issue: |
Pt 11 |
| Pages: |
2698-708 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang Y |
| Year: |
2022 |
| Journal: |
Clin Cancer Res |
| Title: |
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity. |
| Volume: |
28 |
| Issue: |
2 |
| Pages: |
414-424 |
|
•
•
•
•
•
|
| Gene |
|
•
•
•
•
•
|
| Gene |
|
•
•
•
•
•
|
| Gene |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| Gene |
| Type: |
gene |
| Organism: |
frog, African clawed |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kalaitzidis D |
| Year: |
2012 |
| Journal: |
Cell Stem Cell |
| Title: |
mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. |
| Volume: |
11 |
| Issue: |
3 |
| Pages: |
429-39 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant stock, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, mutant stock |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang X |
| Year: |
2020 |
| Journal: |
Nat Metab |
| Title: |
High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy. |
| Volume: |
2 |
| Issue: |
1 |
| Pages: |
110-125 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Peterson TR |
| Year: |
2011 |
| Journal: |
Cell |
| Title: |
mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. |
| Volume: |
146 |
| Issue: |
3 |
| Pages: |
408-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wu T |
| Year: |
2016 |
| Journal: |
Sci Rep |
| Title: |
mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors. |
| Volume: |
6 |
|
| Pages: |
20250 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sparber F |
| Year: |
2014 |
| Journal: |
Blood |
| Title: |
The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis. |
| Volume: |
123 |
| Issue: |
2 |
| Pages: |
217-27 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
124
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sparber F |
| Year: |
2015 |
| Journal: |
J Invest Dermatol |
| Title: |
The late endosomal adaptor molecule p14 (LAMTOR2) regulates TGFβ1-mediated homeostasis of Langerhans cells. |
| Volume: |
135 |
| Issue: |
1 |
| Pages: |
119-129 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Steiner JL |
| Year: |
2015 |
| Journal: |
Alcohol Clin Exp Res |
| Title: |
Alcohol intoxication following muscle contraction in mice decreases muscle protein synthesis but not mTOR signal transduction. |
| Volume: |
39 |
| Issue: |
1 |
| Pages: |
1-10 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang Y |
| Year: |
2013 |
| Journal: |
Diabetes |
| Title: |
MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells. |
| Volume: |
62 |
| Issue: |
3 |
| Pages: |
887-95 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bork T |
| Year: |
2020 |
| Journal: |
Autophagy |
| Title: |
Podocytes maintain high basal levels of autophagy independent of mtor signaling. |
| Volume: |
16 |
| Issue: |
11 |
| Pages: |
1932-1948 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hayama Y |
| Year: |
2018 |
| Journal: |
J Immunol |
| Title: |
Lysosomal Protein Lamtor1 Controls Innate Immune Responses via Nuclear Translocation of Transcription Factor EB. |
| Volume: |
200 |
| Issue: |
11 |
| Pages: |
3790-3800 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
525
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chiu MI |
| Year: |
1994 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. |
| Volume: |
91 |
| Issue: |
26 |
| Pages: |
12574-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Desai BN |
| Year: |
2002 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. |
| Volume: |
99 |
| Issue: |
7 |
| Pages: |
4319-24 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hsu PP |
| Year: |
2011 |
| Journal: |
Science |
| Title: |
The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. |
| Volume: |
332 |
| Issue: |
6035 |
| Pages: |
1317-22 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Budanov AV |
| Year: |
2008 |
| Journal: |
Cell |
| Title: |
p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. |
| Volume: |
134 |
| Issue: |
3 |
| Pages: |
451-60 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Procaccini C |
| Year: |
2010 |
| Journal: |
Immunity |
| Title: |
An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. |
| Volume: |
33 |
| Issue: |
6 |
| Pages: |
929-41 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Squarize CH |
| Year: |
2008 |
| Journal: |
Cancer Res |
| Title: |
Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin. |
| Volume: |
68 |
| Issue: |
17 |
| Pages: |
7066-72 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Brandt C |
| Year: |
2018 |
| Journal: |
Cell |
| Title: |
Food Perception Primes Hepatic ER Homeostasis via Melanocortin-Dependent Control of mTOR Activation. |
| Volume: |
175 |
| Issue: |
5 |
| Pages: |
1321-1335.e20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Huot MÉ |
| Year: |
2012 |
| Journal: |
Mol Cell |
| Title: |
The Sam68 STAR RNA-binding protein regulates mTOR alternative splicing during adipogenesis. |
| Volume: |
46 |
| Issue: |
2 |
| Pages: |
187-99 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bruning U |
| Year: |
2018 |
| Journal: |
Cell Metab |
| Title: |
Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation. |
| Volume: |
28 |
| Issue: |
6 |
| Pages: |
866-880.e15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Viscarra JA |
| Year: |
2020 |
| Journal: |
Nat Commun |
| Title: |
Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis. |
| Volume: |
11 |
| Issue: |
1 |
| Pages: |
796 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yang F |
| Year: |
2020 |
| Journal: |
PLoS One |
| Title: |
Epilepsy in a melanocyte-lineage mTOR hyperactivation mouse model: AÂ novel epilepsy model. |
| Volume: |
15 |
| Issue: |
1 |
| Pages: |
e0228204 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chen X |
| Year: |
2018 |
| Journal: |
Nat Commun |
| Title: |
Phf8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway. |
| Volume: |
9 |
| Issue: |
1 |
| Pages: |
114 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Morquette B |
| Year: |
2015 |
| Journal: |
Cell Death Differ |
| Title: |
REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injury. |
| Volume: |
22 |
| Issue: |
4 |
| Pages: |
612-25 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Blomberg R |
| Year: |
2019 |
| Journal: |
Matrix Biol |
| Title: |
Fibroblast activation protein restrains adipogenic differentiation and regulates matrix-mediated mTOR signaling. |
| Volume: |
83 |
|
| Pages: |
60-76 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Harwood FC |
| Year: |
2018 |
| Journal: |
Sci Adv |
| Title: |
ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer. |
| Volume: |
4 |
| Issue: |
9 |
| Pages: |
eaar3938 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lamouille S |
| Year: |
2012 |
| Journal: |
J Cell Sci |
| Title: |
TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. |
| Volume: |
125 |
| Issue: |
Pt 5 |
| Pages: |
1259-73 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Guo R |
| Year: |
2023 |
| Journal: |
Int Immunopharmacol |
| Title: |
Depletion of mTOR ameliorates CD(4)(+) T cell pyroptosis by promoting autophagy activity in septic mice. |
| Volume: |
124 |
| Issue: |
Pt B |
| Pages: |
110964 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
91
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Camacho A |
| Year: |
2012 |
| Journal: |
Exp Neurol |
| Title: |
Ablation of PGC1 beta prevents mTOR dependent endoplasmic reticulum stress response. |
| Volume: |
237 |
| Issue: |
2 |
| Pages: |
396-406 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cullion K |
| Year: |
2009 |
| Journal: |
Blood |
| Title: |
Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. |
| Volume: |
113 |
| Issue: |
24 |
| Pages: |
6172-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McMahon JJ |
| Year: |
2015 |
| Journal: |
Neurobiol Dis |
| Title: |
Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice. |
| Volume: |
73 |
|
| Pages: |
296-306 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sun H |
| Year: |
2013 |
| Journal: |
Stem Cells |
| Title: |
Osteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling. |
| Volume: |
31 |
| Issue: |
10 |
| Pages: |
2183-92 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang Y |
| Year: |
2014 |
| Journal: |
Cancer Res |
| Title: |
Foxp3+ T cells inhibit antitumor immune memory modulated by mTOR inhibition. |
| Volume: |
74 |
| Issue: |
8 |
| Pages: |
2217-28 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xu X |
| Year: |
2019 |
| Journal: |
FASEB J |
| Title: |
Enhanced mTOR complex 1 signaling attenuates diabetic cardiac injury in OVE26 mice. |
| Volume: |
33 |
| Issue: |
11 |
| Pages: |
12800-12811 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Levitin MO |
| Year: |
2023 |
| Journal: |
Brain |
| Title: |
Models of KPTN-related disorder implicate mTOR signalling in cognitive and overgrowth phenotypes. |
| Volume: |
146 |
| Issue: |
11 |
| Pages: |
4766-4783 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee MN |
| Year: |
2009 |
| Journal: |
Mol Cell Biol |
| Title: |
Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. |
| Volume: |
29 |
| Issue: |
14 |
| Pages: |
3991-4001 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ganesan R |
| Year: |
2017 |
| Journal: |
PLoS Pathog |
| Title: |
Salmonella Typhimurium disrupts Sirt1/AMPK checkpoint control of mTOR to impair autophagy. |
| Volume: |
13 |
| Issue: |
2 |
| Pages: |
e1006227 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dai N |
| Year: |
2011 |
| Journal: |
Genes Dev |
| Title: |
mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. |
| Volume: |
25 |
| Issue: |
11 |
| Pages: |
1159-72 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kadoya M |
| Year: |
2019 |
| Journal: |
Front Neurosci |
| Title: |
Negative Regulation of mTOR Signaling Restricts Cell Proliferation in the Floor Plate. |
| Volume: |
13 |
|
| Pages: |
1022 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schmitt M |
| Year: |
2022 |
| Journal: |
Nature |
| Title: |
Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation. |
| Volume: |
612 |
| Issue: |
7939 |
| Pages: |
347-353 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Turgu B |
| Year: |
2023 |
| Journal: |
EMBO Rep |
| Title: |
The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes. |
| Volume: |
24 |
| Issue: |
12 |
| Pages: |
e56815 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
You JS |
| Year: |
2019 |
| Journal: |
FASEB J |
| Title: |
The role of raptor in the mechanical load-induced regulation of mTOR signaling, protein synthesis, and skeletal muscle hypertrophy. |
| Volume: |
33 |
| Issue: |
3 |
| Pages: |
4021-4034 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nguyen LH |
| Year: |
2015 |
| Journal: |
Epilepsia |
| Title: |
mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia. |
| Volume: |
56 |
| Issue: |
4 |
| Pages: |
636-46 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Feldman ME |
| Year: |
2009 |
| Journal: |
PLoS Biol |
| Title: |
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. |
| Volume: |
7 |
| Issue: |
2 |
| Pages: |
e38 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Luo YD |
| Year: |
2022 |
| Journal: |
Theranostics |
| Title: |
Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling. |
| Volume: |
12 |
| Issue: |
18 |
| Pages: |
7903-7919 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sun Y |
| Year: |
2023 |
| Journal: |
Int Immunopharmacol |
| Title: |
Reduction of peritoneal cavity B1a cells in adult Slc7a5 knockdown mice via dysregulating the mTOR pathway. |
| Volume: |
117 |
|
| Pages: |
109939 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Podsypanina K |
| Year: |
2001 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. |
| Volume: |
98 |
| Issue: |
18 |
| Pages: |
10320-5 |
|
•
•
•
•
•
|
| Allele |
| Name: |
MTOR associated protein, eak-7 homolog; wild type |
| Allele Type: |
Not Specified |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hosokawa T |
| Year: |
2017 |
| Journal: |
J Immunol |
| Title: |
Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive Function. |
| Volume: |
199 |
| Issue: |
6 |
| Pages: |
2008-2019 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ma S |
| Year: |
2015 |
| Journal: |
Exp Eye Res |
| Title: |
Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival. |
| Volume: |
135 |
|
| Pages: |
1-13 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tran Nguyen Truc L |
| Year: |
2023 |
| Journal: |
Sci Rep |
| Title: |
Mechanism of cystogenesis by Cd79a-driven, conditional mTOR activation in developing mouse nephrons. |
| Volume: |
13 |
| Issue: |
1 |
| Pages: |
508 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
724
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Pathway |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wu YF |
| Year: |
2020 |
| Journal: |
Autophagy |
| Title: |
Inactivation of MTOR promotes autophagy-mediated epithelial injury in particulate matter-induced airway inflammation. |
| Volume: |
16 |
| Issue: |
3 |
| Pages: |
435-450 |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li H |
| Year: |
2018 |
| Journal: |
J Biol Chem |
| Title: |
Hepatitis B X-interacting protein promotes the formation of the insulin gene-transcribing protein complex Pdx-1/Neurod1 in animal pancreatic β-cells. |
| Volume: |
293 |
| Issue: |
6 |
| Pages: |
2053-2065 |
|
•
•
•
•
•
|